Skip to main content
. Author manuscript; available in PMC: 2018 Nov 21.
Published in final edited form as: Circulation. 2017 Nov 21;136(21):2068–2082. doi: 10.1161/CIRCULATIONAHA.117.030792

Figure 1.

Figure 1

Schematic representation of the presentation, clinical course and outcome in patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) (14). The majority presented with sustained ventricular arrhythmias (VA) and received an implantable cardioverter-defibrillator (ICD) during follow-up. Printed from Groeneweg et al (14)